Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age from 18 to 65~* Drug resistant epilepsy, partial seizure~* Epilepsy diagnosed for more than 2 years~* Epilepsy treated for more than 1 year with no change of treatment in the month before the enrolment~* Onset of cluster seizure in the 24 hours before enrolment~* For women : effective contraception~* Affiliation to the French social security~Exclusion Criteria:~* Inability to tolerate levetiracetam, likely poor compliance~* Patient taking antiepileptic treatment (benzodiazepine) in addition to current treatment during the last 48h00.~* Patient taking 1g/day of levetiracetam with Creatinin clearance \< 50ml/min~* Patient taking 2g/day of levetiracetam with Creatinin clearance \< 80ml/min~* Patient taking more than 2g/day of levetiracetam~* Hepatic or cardiovascular pathology~* Progressive psychiatric pathology~* Degenerative neurologic disease~* Cluster seizure due to an acute symptomatic reason~* Disorder of consciousness~* Suspicion of status epilepticus or rapid evolution to status epilepticus~* Suspicion of psychogenic nonepileptic seizure~* Pregnant woman or nursing woman~* Suicidal thoughts~* Incapacity to give consent, minor patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).